期刊文献+

冠状动脉介入诊疗术对肾功能影响的532例分析 被引量:14

Contrast-induced nephropathy in 532 patients undergoing coronary intervention
下载PDF
导出
摘要 目的探讨对比剂肾病(contrast-induced nephropathy,CIN)在非选择性患者中的发病率及其危险因素,以及等渗对比剂碘克沙醇的肾安全性。方法共入选532例接受冠状动脉介入诊疗术的患者,测定患者术前1周内任一天及术后48h的肾功能。以术后48h血肌酐(serum creatinine,SCr)较术前升高25%或升高44.2μmol/L(0.5mg/dL)为CIN的诊断标准,分析对比剂对肾功能的影响。用Logistic多因素回归分析CIN发生的危险因素。结果(1)532例患者中29例发生CIN,发病率为5.5%;(2)术前估计肾小球滤过率(estimate glomerular filtration rate,eGFR)<45mL/min的患者CIN发病率显著高于eGFR≥45mL/min的患者(17.5%比4.5%,P=0.002);(3)532例患者中,427例使用低渗对比剂,105例使用等渗对比剂碘克沙醇,低渗对比剂组术前平均eGFR显著高于等渗对比剂组(81.4±27.6mL/min比62.5±22.8mL/min,P=0.000),两者CIN发病率差异无统计学意义(5.6%比4.8%,P=0.797);(4)Logistic多因素分析显示,术前使用利尿剂、术前eGFR<45mL/min、对比剂用量≥500mL是CIN的独立危险因素。结论冠状动脉介入诊疗术后CIN在非选择性患者中的发病率为5.5%。在术前eGFR<45mL/min的患者中CIN的发病率显著升高。等渗对比剂碘克沙醇对肾的安全性可能略优于低渗对比剂。术前使用利尿剂、术前eGFR<45mL/min、对比剂用量≥500mL是CIN的独立危险因素。 Objective To evaluate the incidence of contrast-induced nephropathy (CIN) in nonselected patients undergoing coronary angiography and intervention, and to investigate, the clinic risk factors of CIN as well as the renal safety of isosmolar iodixanol. Methods A total of 532 patients undergoing diagnostic coronary angiography or percutaneous coronary intervention were enrolled. Serum creatinine (SCr) was measured at any time within a week before the procedure and 2 days (48 hours) post procedure. The definition of CIN is the increase of serum creatinine of 44. 2 μmol/L (0. 5 mg/dL) or 25% of the baseline at 48 hours after the use of contrast media. The effects of contrast media on renal function in patients undergoing coronary intervention were investigated and predictors of CIN were determined using logistic regression test. Results ( 1 ) Among the 532 patients, CIN occurred in 29 patients and the incidence of CIN in non-selected patients was 5.5%. (2) The incidence of CIN was significantly higher in patients with baseline eGFR 〈45 mL/min compared with those patients whose baseline eGFR ≥45 mL/min (17.5% vs. 4. 5%, P = 0. 002). (3) A total of 427 patients were given low-osmolality contrast media (LOCM) and 105 patients were given iso-osmolality contrast media (IOCM). The average baseline eGFR in patients provided with LOCM was significantly higher than those with IOCM ( P = 0. 000) but there was no significant difference concerning the incidence of CIN in patients given LOCM compared with those given IOCM ( 5.6% vs. 4. 8% ,P = O. 797 ). (4) Identified by logistic regression, diuretics intake before procedure, basic eGFR 〈 45 mL/min, and volume of contrast-meida more than 500 mL were independent risk factors of CIN. Conclusions The incidence of CIN in oatients undergoing coronary intervention is higher in oatients with basic eGFR 〈45 mL/min than those with eGFR ≥45 mL/min. The renal safety of isosmolar iodixanol may be higher than LOCM. The independent risk factors of CIN are diuretics intake before procedure, basic eGFR 〈 45 mIZmin, and volume of contrast-meida more than 500 mL.
出处 《中国介入心脏病学杂志》 2009年第3期153-156,共4页 Chinese Journal of Interventional Cardiology
关键词 冠状血管造影术 肾病 造影剂 碘克沙醇 Coronary angiography Nephrosis Contrast Media Iodixanol
  • 相关文献

参考文献12

  • 1Berns AS.Nephrotoxicity of contrast media.Kidney Int,1989,36:730-740.
  • 2McCullough PA,Wolyn R,Rocher LL,et al.Acute renal failure after coronary intervention:Incidence,risk factors,and relationship to mortality.Am J Med,1997,103:368-375.
  • 3Toprak O.Risk Markers for Contrast-Induced Nephropathy.Am J Med Sci,2007,334:283-290.
  • 4Thomsen HS,Morcos SK.Contrast media and the kidney:European Society of Urogenital Radiololgy (ESUR) guidelines.Br J Radiol,2003,76:513-518.
  • 5Rich MW,Crecelius CA.Incidence,risk factors,and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older.A prospective study.Arch Intern Med,1990,150:1237-1242.
  • 6吉俊,丁小强,许迅辉,邹建洲,何建强,林贻梅,柏瑾,钱菊英.低渗非离子造影剂对冠状动脉介入诊疗术患者肾功能影响的前瞻性研究[J].中华肾脏病杂志,2006,22(7):388-392. 被引量:46
  • 7来莺,陈万春,赵德强,金惠根.冠状动脉造影对肾功能影响1087例分析[J].岭南心血管病杂志,2006,12(6):398-400. 被引量:4
  • 8Barrett BJ,Carlisle EJ.Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media.Radiology,1993,188:171-178.
  • 9Aspelin P,Aubry P,Fransson S,et al.Nephrotoxic effects in high-risk patients undergoing angiography.N EnglJ Med,2003,348:491-499.
  • 10Jo SH,Youn TJ,Koo BK,et al.Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography:The RECOVER study:A randomized controlled trial.J Am Coll Cardiol,2006,48:924-930.

二级参考文献21

  • 1[1]PARFREY PS,GRIFFITHS SM,BARRET BJ,et al.Contrast material-induced renal failure in patients with diabetes mellitus,renal insufficiency or both.A prospective controlled study[J].N Engl J Med,1989,320(3):143-149.
  • 2[2]WEISBORD SD,PARLESKY DM.Radiocontrast-induced acute renal failure[J].J Intensive Care Med,2005 20(2):63-75.
  • 3[3]MEHRAN R,AYMONG ED,NIKOLSKY E,et al.A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention:development and initial validation[J].J Am Coll Cardiol,44(7):1393-1399.
  • 4[4]COCKCROFT DW,GAULT MH.Prediction of creatintine clearance from serum creatinine[J].Nephron,1976,16(1):31-41.
  • 5[5]HOU FF,ZHANG Y,ZHANG GH,et al.Efficacy and safety of benazepril for advanced chronic renal insufficiency[J].N Engl J Med,2006,354(2):134-140.
  • 6[6]ASPELIN P,AUBRY P,FRANSSON SG,et al.Nephtotoxic effects in high-risk patients undergoing angiography[J].N Engl J Med,2003,348(6):491-497.
  • 7[7]ALONSO A,LAN J,JABER BL,et al.Prevention of radiocontrast nephropathy with N-acetycysteine in patients with chronic kidney disease:a meta-analysis of randomized,controlled trial[J].Am J Kidney Dis,2004,43(1):1-9.
  • 8Best PJ,Lennon R,Ting HH,et al.The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions.J Am Coll Cardiol,2002,39:1113-1119.
  • 9McCullough PA,Wolyn R,Rocher LL,et al.Acute renal failure after coronary intervention:incidence,risk factors,and relationship to mortality.Am J Med,1997,103:368-375.
  • 10Davidson C J,Laskey WK,Hermiller JB,et al.Randomized trial of contrast media utilization in high-risk PTCA:the COURT trial.Circulation,2000,101:2172-2177.

共引文献45

同被引文献133

  • 1吉俊,丁小强,许迅辉,邹建洲,何建强,林贻梅,柏瑾,钱菊英.低渗非离子造影剂对冠状动脉介入诊疗术患者肾功能影响的前瞻性研究[J].中华肾脏病杂志,2006,22(7):388-392. 被引量:46
  • 2Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Catheter Cardiovasc Interv,2008, 71:62-72.
  • 3Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis, 2002,39: 930-936.
  • 4Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease : a position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int, 2005,67 : 2089-2100.
  • 5Roy P, Raya V, Okabe T, et al. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol, 2008,10 : 1544-1549.
  • 6Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol, 2004, 93:1515-1519.
  • 7Lomsso V, Taroni P, Alvino S, et al. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiting hemodialysis. Invest Radiol, 2001,36:309-316.
  • 8Tozawa M, Iseki K, Iseki C, et al. Influence of smoking and obesity on the development of proteinuria. Kidney Int, 2002,62 : 956-962.
  • 9Orth SR, Hallan SI. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients--absence of evidence or evidence of absence? Clin J Am Soc Nephrol,2008,3:226-236.
  • 10苏海华.造影剂肾病的诊疗进展[J].国际移植及血液净化杂志,2006,4(3):1-4.

引证文献14

二级引证文献138

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部